Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Tivic Health Systems
Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod
May 19, 2026
Tivic CEO To Present at the Upcoming Emerging Growth’s April 2026 Virtual Conference
May 19, 2026
Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome
May 18, 2026
Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET
May 18, 2026
Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting
January 28, 2026
Tivic CEO To Present at the Upcoming Emerging Growth’s January 2026 Virtual Conference
January 20, 2026
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
January 12, 2026
Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets – Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines
January 8, 2026
Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package
December 12, 2025